Journal

PharmacoEconomics - Open

2509-4262 · Springer Science and Business Media LLC

104 verified public works

Browse all journals →

Budget Impact Model of a Novel cfRNA Test-and-Treat Strategy for Preeclampsia in Advanced Maternal Age Pregnancies Compared with Current Guidelines

2026 · 0 citations

Cost-Effectiveness Analysis of Ribociclib plus an Aromatase Inhibitor (AI) Versus AI Alone in the Adjuvant Treatment of Stage II and III Pre- and Postmenopausal Women with HR+/HER2− Early Breast Cancer (EBC): A Canadian Payer Perspective

2026 · 0 citations

Generalized Pustular Psoriasis: A Cost-of-Illness and Health-Related Quality of Life Study in Italy

2026 · 0 citations

Healthcare Utilization and Direct Medical Costs of Hepatocellular Carcinoma Treatment — A German Claims Data Study of 2778 Patients

2026 · 0 citations

Strimvelis® for Treating Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency: An Evidence Review Group Perspective of a NICE Highly Specialised Technology Evaluation

2018 · 0 citations

Economic Burden of Patients Treated for Higher-Risk Myelodysplastic Syndromes (HR-MDS) in Routine Clinical Care in the United States

2018 · 0 citations

Working with Patients and Members of the Public: Informing Health Economics in Child Health Research

2018 · 0 citations

Time and Cost of Hospitalisation for Salvage Therapy in Adults with Philadelphia Chromosome-Negative B Cell Precursor Relapsed or Refractory Acute Lymphoblastic Leukaemia in Spain

2018 · 0 citations

Evaluating the Outcomes Associated with Genomic Sequencing: A Roadmap for Future Research

2018 · 0 citations

Correction to: Cost-Effectiveness Analysis of Single-Use EEG Cup Electrodes Compared with Reusable EEG Cup Electrodes

2018 · 0 citations

Correction to: Can We Accurately Predict Cost Effectiveness Without Access to Overall Survival Data? The Case Study of Nivolumab in Combination with Ipilimumab for the Treatment of Patients with Advanced Melanoma in England

2018 · 0 citations

Does Structured Exercise Improve Cognitive Impairment in People with Mild to Moderate Dementia? A Cost-Effectiveness Analysis from a Confirmatory Randomised Controlled Trial: The Dementia and Physical Activity (DAPA) Trial

2018 · 0 citations

Value Assessment Frameworks in the United States: A Call for Patient Engagement

2018 · 0 citations

High Healthcare Resource Use in Hospitalized Patients with a Diagnosis of Spinal Muscular Atrophy Type 1 (SMA1): Retrospective Analysis of the Kids’ Inpatient Database (KID)

2018 · 0 citations

The Psychometric Properties of a Self-Administered, Open-Source Module for Valuing Metastatic Epidural Spinal Cord Compression Utilities

2018 · 0 citations

Cost Comparison of Single-Use Versus Reusable Bronchoscopes Used for Percutaneous Dilatational Tracheostomy

2018 · 0 citations

Cost-Effectiveness Analysis of Single-Use EEG Cup Electrodes Compared with Reusable EEG Cup Electrodes

2018 · 0 citations

Adherence, Healthcare Resource Utilization, and Costs in Medicaid Beneficiaries with Schizophrenia Transitioning from Once-Monthly to Once-Every-3-Months Paliperidone Palmitate

2018 · 0 citations

International HTA Experience with Targeted Therapy Approvals for Lung Cancer

2018 · 0 citations

Measuring the Benefits of Decision Aids for Economic Evaluation

2018 · 0 citations

Influence of Idiopathic Pulmonary Fibrosis Progression on Healthcare Resource Use

2018 · 0 citations

Cost Effectiveness of Long-Term Incobotulinumtoxin-A Treatment in the Management of Post-stroke Spasticity of the Upper Limb from the Australian Payer Perspective

2018 · 0 citations

Conducting a Time Trade-Off Study Alongside a Clinical Trial: A Case Study and Recommendations

2018 · 0 citations

Developing Accessible, Pictorial Versions of Health-Related Quality-of-Life Instruments Suitable for Economic Evaluation: A Report of Preliminary Studies Conducted in Canada and the United Kingdom

2018 · 0 citations

Assessing the Impact of Growth Hormone Deficiency (GHD) in Adults: Interpreting Change of the Treatment-Related Impact Measure—Adult Growth Hormone Deficiency (TRIM-AGHD)

2018 · 0 citations

Can We Accurately Predict Cost Effectiveness Without Access to Overall Survival Data? The Case Study of Nivolumab in Combination with Ipilimumab for the Treatment of Patients with Advanced Melanoma in England

2018 · 0 citations

Reduction of Direct Health Costs Associated with Pertussis Vaccination with Acellular Vaccines in Children Aged 0–9 Years with Pertussis in Catalonia (Spain)

2018 · 0 citations

Including Future Consumption and Production in Economic Evaluation of Interventions that Save Life-Years: Commentary

2018 · 0 citations

Accommodation and Health Costs of Deinstitutionalized People with Mental Illness Living in Residential Services in Brazil

2018 · 0 citations

Cost-Effectiveness of Aspirin Adherence for Secondary Prevention of Cardiovascular Events

2018 · 0 citations